Discovering a new world of therapeutics

The therapeutic potential of the human transcriptome, the set of all RNAs transcribed from DNA, remains largely unexplored. By harnessing new insights into RNA structure and dynamics, Arrakis is opening the transcriptome to therapy by small-molecule medicines to treat patients not cured by today’s medicines. We aim to unlock the therapeutic potential of deeply researched, valuable targets and to identify new disease intervention points that may be uniquely addressed with RNA-targeted small molecules.

Drug-Likeness and RNA-Targeted Small Molecules
Mar 13, 2018
Thomas Hermann
RNA Dynamics – A Bug or a Feature?
Feb 14, 2018
Donovan Chin
The prospect of RNA targeting using small molecules
Dec 13, 2017
David Chenoweth, PhD
Back to Top